These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14737082)

  • 1. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity.
    Zhang YC; Powers M; Wasserfall C; Brusko T; Song S; Flotte T; Snyder RO; Potter M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick HS; Agarwal A; Ellis TM; Atkinson MA
    Gene Ther; 2004 Feb; 11(3):233-40. PubMed ID: 14737082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer into skeletal muscle using novel AAV serotypes.
    Louboutin JP; Wang L; Wilson JM
    J Gene Med; 2005 Apr; 7(4):442-51. PubMed ID: 15517544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
    Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
    Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
    Rivière C; Danos O; Douar AM
    Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses.
    De BP; Heguy A; Hackett NR; Ferris B; Leopold PL; Lee J; Pierre L; Gao G; Wilson JM; Crystal RG
    Mol Ther; 2006 Jan; 13(1):67-76. PubMed ID: 16260185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement is an essential component of the immune response to adeno-associated virus vectors.
    Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
    J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
    Le HT; Yu QC; Wilson JM; Croyle MA
    J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
    Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
    Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration.
    Brockstedt DG; Podsakoff GM; Fong L; Kurtzman G; Mueller-Ruchholtz W; Engleman EG
    Clin Immunol; 1999 Jul; 92(1):67-75. PubMed ID: 10413654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
    Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
    Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates.
    Gao G; Lu Y; Calcedo R; Grant RL; Bell P; Wang L; Figueredo J; Lock M; Wilson JM
    Mol Ther; 2006 Jan; 13(1):77-87. PubMed ID: 16219492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can genes transduced by adeno-associated virus vectors elicit or evade an immune response?
    Wang CH; Liu DW; Tsao YP; Xiao X; Chen SL
    Arch Virol; 2004 Jan; 149(1):1-15. PubMed ID: 14689272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adeno-associated virus vectors.
    Kunze M; Huber A; Krajewski A; Lowden E; Schuhmann N; Buening H; Hallek M; Noack M; Perabo L
    J Dent; 2009 Jul; 37(7):502-8. PubMed ID: 19362764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
    Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
    Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer.
    Ghosh A; Allamarvdasht M; Pan CJ; Sun MS; Mansfield BC; Byrne BJ; Chou JY
    Gene Ther; 2006 Feb; 13(4):321-9. PubMed ID: 16195703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.